Non-Ossifying Fibroma
Is your child suffering from bone pain or a benign tumor diagnosed incidentally? Non-ossifying fibroma is a common benign bone lesion in children and adolescents. In Tunisia, experienced orthopedists provide diagnosis and treatment for this condition, with competitive prices and personalized care.
Non-Ossifying Fibroma : Definition
A non-ossifying fibroma, also known as a cortical fibrous lesion or fibrous metaphyseal defect, is a benign tumor that affects bones. This lesion is generally composed of fibrous tissue and is often diagnosed in children and adolescents (between 5 and 15 years), with a male predominance.
Non-ossifying fibroma is a non-cancerous lesion that has no malignant potential. It never transforms into cancer and does not metastasize. In the majority of cases, it is asymptomatic and resolves spontaneously with growth.
Causes of Non-Ossifying Fibroma
The exact causes of non-ossifying fibromas are still unknown. Genetic factors with a family predisposition are possible. A hormonal imbalance related to growth hormones is suspected. Mechanical factors, such as repeated stress on the bone, may contribute. Finally, minor repeated trauma could play a role.
Symptoms of Non-Ossifying Fibroma
Non-ossifying fibromas are often asymptomatic and discovered incidentally. However, symptoms may appear. Intermittent or constant bone pain is aggravated by physical activity. Local swelling may form. Limitation of movement or joint stiffness is possible. Pathological fracture occurs in rare cases. A limp may appear if the lesion is near a joint.
Diagnosis of Non-Ossifying Fibroma
Diagnosis is based on several imaging examinations. X-ray is the first-line examination, showing a well-defined lesion. CT scan allows precise assessment of the extent and structure of the lesion. MRI is useful to differentiate fibroma from other bone tumors. Bone biopsy is rarely necessary, reserved for atypical cases.
Treatment Options
Treatment of non-ossifying fibroma depends on the size of the lesion, its location and symptoms:
1. Monitoring (Conservative Treatment)
Observation is recommended for asymptomatic small lesions. Regular radiological monitoring is performed every 6 to 12 months. The lesion resolves spontaneously in the majority of cases with growth.
2. Medical Treatment
Conservative treatment of non-ossifying fibroma is based on several measures. Analgesics are prescribed to control mild to moderate pain. Anti-inflammatory drugs are used in case of inflammatory pain. Rest with limitation of physical activities is recommended in the presence of pain.
3. Surgery
Surgery is indicated in the following cases. A symptomatic lesion with persistent pain justifies the intervention. A large lesion with risk of fracture is an indication. A progressive lesion despite monitoring also requires surgery. Finally, a weakening location in the lower limb may lead to it.
Surgical Procedure
Non-ossifying fibroma surgery takes place in several steps. General or regional anesthesia is performed. An incision allows direct access to the lesion. Curettage excises the tumor and fibro-lipomatous tissues. Bone graft fills the bone defect. Osteosynthesis stabilizes the bone if necessary. Closure is done with sutures and a dressing.
Post-Operative Recovery
Post-operative recovery after non-ossifying fibroma surgery is well codified. Hospitalization lasts 2 to 4 days depending on complexity. Immobilization with a brace or cast is necessary for 3 to 6 weeks. Rehabilitation through physiotherapy restores mobility and strength. Return to activities is progressive after 2 to 3 months. Follow-up is provided with control X-rays at 1, 3, 6 months and 1 year.
Advantages of Surgery
Non-ossifying fibroma surgery allows complete removal of the tumor. It provides pain relief. It restores bone function. It reduces the risk of fracture. It improves quality of life. The recurrence rate is low, less than 5%.
Risks and Potential Complications
Several complications may occur after non-ossifying fibroma surgery. Infection is rare and prevented by antibiotic prophylaxis. Bleeding is controlled during the procedure. Risk of fracture is prevented by immobilization. Nerve damage is rare. Recurrence is less than 5% after complete excision. Joint stiffness is prevented by early rehabilitation.
Prices for Non-Ossifying Fibroma Surgery in Tunisia
Tunisia offers very competitive prices for non-ossifying fibroma surgery. Consultation and assessment cost between €100 and €200. Surgery with curettage is offered from €2,000 to €3,500. Surgery with bone graft costs from €3,000 to €5,000. Osteosynthesis with screws or plate is available from €4,000 to €6,000. Packages include consultation, imaging, surgery, hospitalization, post-operative care and medical follow-up.
Frequently Asked Questions about Non-Ossifying Fibroma
1Is non-ossifying fibroma a cancerous tumor?
No, non-ossifying fibroma is a benign tumor. It is a cortical fibrous lesion that has no malignant potential. It never transforms into cancer and does not metastasize.
2Who is most affected by non-ossifying fibromas?
Non-ossifying fibromas mainly affect children and adolescents (between 5 and 15 years), with a male predominance (2 boys for 1 girl). The lesion is generally discovered incidentally during an X-ray for another reason.
3Can a non-ossifying fibroma disappear spontaneously?
Yes, in the majority of cases, non-ossifying fibroma is asymptomatic and resolves spontaneously with growth. The lesion evolves towards progressive ossification and generally disappears in adulthood (around 20-25 years).
4How long is the hospital stay for non-ossifying fibroma surgery in Tunisia?
Hospitalization is generally short, 2 to 4 days depending on the complexity of the procedure and the location of the tumor. Post-operative monitoring is provided before returning home.
5What is the price of non-ossifying fibroma surgery in Tunisia?
The price of non-ossifying fibroma surgery in Tunisia ranges from €2,000 to €5,000 depending on the size of the tumor, its location and the surgical technique used. This package includes consultation, imaging examinations, surgery, hospitalization and post-operative follow-up.
6What are the risks of recurrence after non-ossifying fibroma surgery?
The recurrence rate after complete surgery is very low, less than 5%. Incomplete excision may lead to local recurrence. Regular radiological follow-up is recommended to monitor evolution.
7When can a child with non-ossifying fibroma return to sports?
Return to sports depends on treatment: in case of simple monitoring, the child can practice normal activity. After surgery, return is progressive, generally after 2 to 3 months, with full return to sports after 4 to 6 months according to the surgeon's advice.
Why Choose Tunisia for Non-Ossifying Fibroma Treatment?
Our orthopedists are experienced and specialized in pediatric and tumor bone surgery. We have modern equipment with high-quality imaging. Our prices are competitive, 40 to 60% cheaper than in Europe. Care is rapid with appointments within 48 hours. Personalized follow-up is provided pre and post-operatively.
In Conclusion
Non-ossifying fibroma is a benign bone tumor common in children and adolescents. In the majority of cases, it is asymptomatic and resolves spontaneously. When surgical treatment is necessary, Tunisia offers quality care at competitive prices, with experienced orthopedists and modern equipment. Do not hesitate to contact us for a personalized and free quote.